Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Abciximab ReoPro

Abciximab (ReoPro) Aspirin (Bayer, Ecotrin, St. Joseph s) Clopidogrel (Plavix)... [Pg.50]

FFeart disease, particularly clogged blood vessels, is also treated with recombinant products. Alteplase (Activase ), a human recombinant protein that breaks down fibrin, is used immediately after a stroke or heart attack to break down platelet-trapping clots in small blood vessels of the heart or brain and thus improve the patient s chances for recovery. Purified enzymes from bacteria are used for the same purposes. Abciximab (ReoPro ), a monoclonal antibody to... [Pg.78]

Parenteral 250 mg/vial lyophilized powder Abciximab (ReoPro)... [Pg.1205]

Abciximab ReoPro Unstable angina (percutaneous coronary intervention) 1994... [Pg.88]

Abciximab (ReoPro) Tirofiban (aggrastat) Eptifibatide (integrilin)... [Pg.43]

Kim W, Jeong MH, Hong YJ, et al. The long-term clinical results of a platelet glycoprotein llb/llla receptor blocker (Abciximab Reopro) coated stent in patients with coronary artery disease, Korean J Intern Med 2004 I 9(4) 220-229,... [Pg.260]

Abciximab ReoPro Centocor Anti-GPIIb/ Ha Fab Cardiovascular 1997... [Pg.591]

Abciximab ReoPro (Centocor/Eli Lilly) Prevention of blood clots after PTCA or any coronary intervention unstable angina prior to PTCA... [Pg.273]

Abciximab ReoPro (Centocor) Fab fragment of chimeric anti-7E3 Platelet aggregation inhibitor (Coronary intervention)... [Pg.1137]

Sharma S, Bhambi B, Nyitray W, Sharma G, Shambaugh S, Antonescu A, Shukla P, Denny E. Delayed profound thrombocytopenia presenting 7 days after use of abciximab (ReoPro). J Cardiovasc Pharmacol Ther 2002 7(1) 21. ... [Pg.7]

Abciximab ReoPro, c7E3 Fab EPIC Phase III Completed [170], [168]... [Pg.77]

Abciximab ReoPro Centocor, chimeric Fab GPIIb/IIIa percutaneous 1995 Fab 6% ... [Pg.1152]

Tam, S.H., Sassoli, P.M., Jordan, R. E., Naka-da, M.T. Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein Ilb/llla and Oyfl integrins. Circulation 1998, 98, 1085-1091. [Pg.1183]

Abciximab (ReoPro) is the Fab fragment of a humanized monoclonal antibody directed against the a bp3 receptor. It also binds to the vitronectin receptor on platelets, vascular endothelial cells, and smooth-muscle cells. The antibody is used in conjunction with percutaneous angioplasty for coronary thromboses, and when used in conjunction with aspirin and heparin, has been shown to be quite effective in preventing restenosis, recurrent myocardial infarction, and death. [Pg.35]

ABCIXIMAB Abciximab (REOPRO) is the Fab fragment of a humanized monoclonal antibody directed against the receptor. It also binds to the vitronectin receptor on platelets, vascular... [Pg.963]

Abciximab (ReoPro) was the first partially humanized antibody approved for therapeutic use. It was produced from transgenic murine melanoma cells containing human heavy-chain genes so that the resulting Fab fragment is a chimera of human and mouse Ab fragments. Abciximab binds to the glycoprotein llb/llla... [Pg.721]

Abciximab ReoPro Chimeric Adjunct to PTCA for prevention of acute cardiac complications... [Pg.240]

Abciximab (ReoPro) 1994 Chimeric 47.6 8.4 L 0.1 6-0.5 h (but remains on platelets for weeks) IV injection and infusion (1.0) Inhibits platelet aggregation by targeting glycoprotein lib/ Ilia receptor Prevention of thrombosis in percutaneous coronary intervention... [Pg.352]

Glycoprotein Ilb/IIIa antagonists Abciximab Reopro IV Launched... [Pg.549]

See other pages where Abciximab ReoPro is mentioned: [Pg.2]    [Pg.334]    [Pg.263]    [Pg.280]    [Pg.347]    [Pg.555]    [Pg.771]    [Pg.59]    [Pg.115]    [Pg.350]    [Pg.353]    [Pg.782]    [Pg.1358]    [Pg.526]    [Pg.114]    [Pg.369]    [Pg.1569]    [Pg.1153]    [Pg.49]    [Pg.59]    [Pg.715]    [Pg.333]    [Pg.109]   
See also in sourсe #XX -- [ Pg.1569 ]



SEARCH



Abciximab

© 2024 chempedia.info